These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 22984562)

  • 1. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
    de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
    PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic reprogramming as a key contributor to melanocyte malignant transformation.
    Molognoni F; Cruz AT; Meliso FM; Morais AS; Souza CF; Xander P; Bischof JM; Costa FF; Soares MB; Liang G; Jones PA; Jasiulionis MG
    Epigenetics; 2011 Apr; 6(4):450-64. PubMed ID: 21343701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis.
    Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG
    Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
    Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
    Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
    Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
    Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
    Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
    Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
    Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
    Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
    Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
    Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.
    Heimerl S; Bosserhoff AK; Langmann T; Ecker J; Schmitz G
    Melanoma Res; 2007 Oct; 17(5):265-73. PubMed ID: 17885581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis.
    Marie KL; Sassano A; Yang HH; Michalowski AM; Michael HT; Guo T; Tsai YC; Weissman AM; Lee MP; Jenkins LM; Zaidi MR; Pérez-Guijarro E; Day CP; Ylaya K; Hewitt SM; Patel NL; Arnheiter H; Davis S; Meltzer PS; Merlino G; Mishra PJ
    Nat Commun; 2020 Jan; 11(1):333. PubMed ID: 31949145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells.
    Liu S; Howell PM; Riker AI
    Ann Surg Oncol; 2013 May; 20(5):1745-52. PubMed ID: 22752337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
    Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
    Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cDNA-array profiling of melanomas and paired melanocyte cultures.
    Mischiati C; Natali PG; Sereni A; Sibilio L; Giorda E; Cappellacci S; Nicotra MR; Mariani G; Di Filippo F; Catricalà C; Gambari R; Grammatico P; Giacomini P
    J Cell Physiol; 2006 Jun; 207(3):697-705. PubMed ID: 16523488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global analysis of gene expression changes during retinoic acid-induced growth arrest and differentiation of melanoma: comparison to differentially expressed genes in melanocytes vs melanoma.
    Estler M; Boskovic G; Denvir J; Miles S; Primerano DA; Niles RM
    BMC Genomics; 2008 Oct; 9():478. PubMed ID: 18847503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
    Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
    Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
    J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
    Mori T; Kim J; Yamano T; Takeuchi H; Huang S; Umetani N; Koyanagi K; Hoon DS
    Cancer Res; 2005 Mar; 65(5):1800-7. PubMed ID: 15753377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.